Chronic Inotropic Therapy in the Current Era: Old Wines With New Pairings

Affiliations

¹ From the Department of Medicine, Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (S.P.P.); and Advanced Heart Disease Section, Heart and Vascular Center, Brigham and Women's Hospital, Boston, MA (L.W.S.). sean.pinney@mssm.edu.
² From the Department of Medicine, Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (S.P.P.); and Advanced Heart Disease Section, Heart and Vascular Center, Brigham and Women's Hospital, Boston, MA (L.W.S.).

Editorial

Sean P Pinney et al. Circ Heart Fail. 2015 Sep.

. 2015 Sep;8(5):843-6.

doi: 10.1161/CIRCHEARTFAILURE.115.002481.

¹ From the Department of Medicine, Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (S.P.P.); and Advanced Heart Disease Section, Heart and Vascular Center, Brigham and Women's Hospital, Boston, MA (L.W.S.). sean.pinney@mssm.edu.
² From the Department of Medicine, Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (S.P.P.); and Advanced Heart Disease Section, Heart and Vascular Center, Brigham and Women's Hospital, Boston, MA (L.W.S.).

No abstract available

Keywords: Editorials; heart failure; inotropes; palliative care.

Comment on

Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.
Hashim T, Sanam K, Revilla-Martinez M, Morgan CJ, Tallaj JA, Pamboukian SV, Loyaga-Rendon RY, George JF, Acharya D. Hashim T, et al. Circ Heart Fail. 2015 Sep;8(5):880-6. doi: 10.1161/CIRCHEARTFAILURE.114.001778. Epub 2015 Jul 15. Circ Heart Fail. 2015. PMID: 26179184 Clinical Trial.